Informations générales (source: ClinicalTrials.gov)

NCT03436212 Statut inconnu
Real-Life Home Glucose Monitoring Over 14 Days in T2D Patients With Intensified Therapy Using Insulin Pump. The CLOSE Study (CLOSE)
Interventional
  • Diabète de type 2
N/A
Air Liquide Santé International (Voir sur ClinicalTrials)
septembre 2017
mars 2018
29 juin 2024
This study aims at describing the glucose level by automated glucose sensors and correlating it with insulin delivery and meals over 14 days in insulin-requiring T2D patients living in real-life conditions.

Etablissements

Les établissements hors Île-de-France dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données
CHU de Caen, Service Endocrinologie, Diabétologie - 14033 - Caen - France Yves Reznik, MD En recrutement Contact (sur clinicalTrials)

Critères

Tous
Selection criteria:

- Type 2 Diabetes diagnosed for at least 5 years

- Treated with insulin pump for at least 6 months

- 7.5% ≤ HBA1c ≤ 10% (last available value dated less than 3 months)

- Having given his/her free, express and informed consent to participate to the study

Inclusion Criteria:

- 7.5% ≤ HBA1c ≤ 10% (result of the dosage performed at selection visit)

- Daily insulin requirement ≤ 1.5U/kg/day

- Having been compliant to take pictures of his/her meals and snacks over the 3 days
prior to the inclusion visit

Non-selection/Non-inclusion criteria:

- Pregnant or breastfeeding woman

- Comorbidity which, in the investigator's opinion, could jeopardize the study
completion

- Patient with difficulties to understand the study procedures or deemed unfit, by the
Investigator, to comply with operating instructions of CGM equipment.